Christian Angermayer is an entrepreneur and investor. He is founder of Apeiron Investment Group, his family office, and merchant banking business. He co-founded Ribopharma, which has $13bn market cap today, and he has raised over $2bn for his portfolio companies. Christian is a significant investor in European fintech companies with a special focus on cryptocurrencies and blockchain-related business models. His biotech companies Atai Life Sciences, Rejuveron and Cambrian are developing cutting edge drugs and technologies to improve health.